SLC2A9 and chronic kidney disease: One candidate gene study that focused on 11 urate transporters reported that the strength of association - as quantified by the association p-value - between genetic variants in ABCG2 was stronger in patients with CKD compared to 481 population-based individuals, while the opposite was observed for variants in SLC2A99.